Veracyte | VCYT - Interest Expense On Debt


Veracyte reported $2K in Interest Expense on Debt for its fiscal quarter ending in December of 2023.





Interest Expense On Debt Change Date
Agenus USD 12.8M 7.89M Mar/2025
Agilent USD 27M 1000K Sep/2025
Anika Therapeutics 189.44M 1.76M Sep/2025
Arrowhead Research USD 22.5M 811K Dec/2025
Bruker USD 20M 4.3M Sep/2025
Exact Sciences USD 9.79M 46K Sep/2025
Heron Therapeutics USD 500K 900K Sep/2024
Illumina USD 25M 0 Sep/2025
Intrexon USD 2K 5K Jun/2024
Karyopharm Therapeutics USD 11.38M 2.43M Sep/2024
Laboratory Of America USD 55M 1000K Dec/2025
Ligand Pharmaceuticals USD 910K 243K Sep/2025
Myriad Genetics USD 800K 100K Mar/2025
Rigel Pharmaceuticals USD 2.06M 31K Sep/2024
Roche Holding CHF 304M 7.5M Jun/2025
Sangamo BioSciences 97.56M 11.39M Jun/2025
Siemens EUR 435M 1000K Dec/2025
Sonic Healthcare AUD 86.91M 43.94M Dec/2024
Thermo Fisher Scientific USD 365M 18M Dec/2025
Veracyte USD 2K 1000 Dec/2023
Waters USD 8.62M 18.02M Dec/2025